000 01416 a2200385 4500
005 20250517203832.0
264 0 _c20180625
008 201806s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0192949
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBalbas-Martinez, Violeta
245 0 0 _aA systems pharmacology model for inflammatory bowel disease.
_h[electronic resource]
260 _bPloS one
_c2018
300 _ae0192949 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlgorithms
650 0 4 _aComputer Simulation
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aInterferon-gamma
_xantagonists & inhibitors
650 0 4 _aInterleukin-17
_xantagonists & inhibitors
650 0 4 _aMatrix Metalloproteinases
_xmetabolism
650 0 4 _aModels, Biological
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aRuiz-Cerdá, Leire
700 1 _aIrurzun-Arana, Itziar
700 1 _aGonzález-García, Ignacio
700 1 _aVermeulen, An
700 1 _aGómez-Mantilla, José David
700 1 _aTrocóniz, Iñaki F
773 0 _tPloS one
_gvol. 13
_gno. 3
_gp. e0192949
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0192949
_zAvailable from publisher's website
999 _c28154224
_d28154224